Back
Principal Financial Group Vs. Novo Nordisk AS Industry Stock Comparison
Sell
31
PFG
Principal Financial Group
Last Price:
$77.94
Seasonality Move:
-1.91%
Sell
26
NVO
Novo Nordisk AS
Last Price:
$87.66
Seasonality Move:
6.4%
Sell
31
Principal Financial Group (PFG)
is a Sell
Is Principal Financial Group a Buy, Sell or Hold?
-
The current Principal Financial Group [PFG] share price is $77.91. The Score for PFG is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
PFG is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
26
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NVO] share price is $87.65. The Score for NVO is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PFG Stock Price Chart
What is Principal Financial Group's stock price today?
-
The Principal Financial Group share price today is $77.91Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PFG is experiencing buying pressure, which is a positive indicator for future bullish movement.
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $87.65Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight selling pressure.
PFG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.73 | Sell |
Relative Strength Index (14 RSI): | 39.52 | Sell |
Chaikin Money Flow: | 766084 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (76.52 - 83.78) | Sell |
Bollinger Bands (100): | (78.6 - 87.06) | Sell |
NVO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.01 | Sell |
Relative Strength Index (14 RSI): | 30.1 | Sell |
Chaikin Money Flow: | -992739 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (90.25 - 110.97) | Sell |
Bollinger Bands (100): | (101.58 - 130.52) | Sell |
PFG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 77.65 | Buy |
20-day SMA: | 78.71 | Sell |
50-day SMA: | 82.77 | Sell |
200-day SMA: | 82.09 | Sell |
8-day EMA: | 77.67 | Buy |
20-day EMA: | 79.02 | Sell |
50-day EMA: | 81.46 | Sell |
200-day EMA: | 81.59 | Sell |
NVO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 87.25 | Buy |
20-day SMA: | 98.78 | Sell |
50-day SMA: | 104.32 | Sell |
200-day SMA: | 124.42 | Sell |
8-day EMA: | 89.14 | Sell |
20-day EMA: | 95.42 | Sell |
50-day EMA: | 103.78 | Sell |
200-day EMA: | 115.72 | Sell |
Principal Financial Group Earnings Growth & PFG Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.36 per share, and an increase next year of $0.91 per share.
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.72 per share, and an increase next year of $0.66 per share.
Principal Financial Group Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |